Pfizer Q1 Results: Co lifts profit view on cost cuts, smaller drop in Paxlovid

Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cutting efforts and stronger-than-expected sales of its COVID antiviral treatment.